rethinkPeptides Search
Menu
Study breakdown

Disulfide Bond in Lactoferricin Boosts Antibacterial Activity Against Mastitis Pathogen

In VitroPreliminary evidence
The takeaway

The intramolecular disulfide bond in bovine lactoferricin enhances its structural stability and antibacterial activity against Trueperella pyogenes mastitis isolates.

Disulfide bond enhances activity

bLfcin with intact disulfide bond showed highest antibacterial activity against T. pyogenes mastitis isolates

What the researchers found

The intramolecular disulfide bond in bLfcin increased β-turn structure and enhanced antibacterial activity against T. pyogenes mastitis isolates compared to derivatives without the bond.

Why it matters

Bovine mastitis causes significant economic losses in dairy farming. Understanding what makes lactoferricin effective against mastitis pathogens could lead to peptide-based udder treatments.

The numbers in context

3 peptide variants; DB form had most beta-turn structure; all more active against T. pyogenes than E. coli

How the study worked

In-vitro study synthesizing three bLfcin variants, characterizing structure by circular dichroism in different ionic/hydrophobic conditions, and testing antibacterial activity against T. pyogenes and E. coli.

Who was studied

T. pyogenes isolates from cow mastitis milk, T. pyogenes ATCC 19411, E. coli ATCC 25922

What this study cannot tell us

In-vitro study only; limited bacterial strains tested; clinical relevance for mastitis treatment not established; mechanism of enhanced activity beyond structural changes not explored.

How to read the evidence

Preliminary in-vitro study with clear structure-activity relationship, but limited to two bacterial species and no in-vivo testing.

When this study was published

Published in 2020; lactoferricin and other milk-derived AMPs continue to be explored for veterinary and human applications.

The bigger picture

This demonstrates how a single structural feature — a disulfide bond — can determine antimicrobial peptide effectiveness, providing design principles for engineering better AMP therapeutics.

Questions still open

  • Could bLfcin DB be used as an intramammary treatment for bovine mastitis?
  • How does the disulfide bond affect bLfcin interaction with bacterial membranes specifically?
  • Would cyclic versions of lactoferricin show even greater antimicrobial activity?

Common questions

What is lactoferricin?
An antimicrobial peptide naturally found in cow milk, produced from the protein lactoferrin. It has antibacterial activity against a range of pathogens including those causing udder infections.
Can milk peptides fight infections?
Yes — lactoferricin from cow milk shows strong antibacterial activity, especially when its structural disulfide bond is intact, making it a potential natural treatment for mastitis.

Read the original research

Effect of intramolecular disulfide bond of bovine lactoferricin on its molecular structure and antibacterial activity against Trueperella pyogenes separated from cow milk with mastitis.

BMC veterinary research, 16(1), 401

Citation

Pei, Jie; Xiong, Lin; Chu, Min; Guo, Xian; Yan, Ping. (2020). Effect of intramolecular disulfide bond of bovine lactoferricin on its molecular structure and antibacterial activity against Trueperella pyogenes separated from cow milk with mastitis.. BMC veterinary research, 16(1), 401. https://doi.org/10.1186/s12917-020-02620-z